Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
PCT Effective to ID Invasive Bacterial Infection in Febrile Infants
...
Register
Chronix Uses cfDNA to Change Screening for Common Cancers
...
Register
Paper-Based Test May Increase Male Fertility Self-Testing
...
Register
Mass Spec Use Expanding Throughout Clinical Laboratory Medicine
...
Register
Cost Effectiveness of Nail Fungus Confirmatory Test Treatment-Specific
...
Register
Labs Must Weigh Economics of ALK Mutation Testing Strategies
...
Register
Daily INR Measurement for Inpatients Could Improve Safety
...
Register
Guidelines for Zika Testing and Safety Issued
From - National Intelligence Report
The Zika virus is getting increased attention from U.S. media and the Centers for Disease Control and Prevention (CDC) now that the first case of the infection has been detected in a…
Few Non-Academic Hospitals Planning for Precision Medicine
From - Diagnostic Testing & Emerging Technologies
Except for academic medical centers, few hospital executives see personalized medicine playing a significant role at their organization…
Illumina Enters Into Biobanking Deal With Four Major Health Care Providers
From - Laboratory Industry Report
San Diego-based Illumina has entered into biobanking deals with four major health care providers, allowing it to genotype tens of thousands of genetic specimens…
